Navigation Links
Experts Issue New Guidelines on Breast Cancer Drugs
Date:7/13/2010

By Amanda Gardner
HealthDay Reporter

TUESDAY, July 13 (HealthDay News) -- A leading group of cancer experts has issued new guidelines on the best way to use two classes of hormone therapies for estrogen receptor-positive breast cancer, the most common form of breast tumor.

After a systematic review of medical research on the subject, experts reported that adding an aromatase inhibitor -- a drug that reduces the amount of estrogen produced in the body -- has clearly been shown to reduce the number of tumor recurrences in postmenopausal women compared with the standard drug tamoxifen, which works by blocking the action of estrogen on cancer tumors that are estrogen-receptor positive.

The committee preparing the guidelines recommended, therefore, that all postmenopausal women with this type of breast cancer use aromatase inhibitors either before or after tamoxifen.

They also concluded that women could use them as long as five years after tamoxifen therapy to lower their risk that the cancer will reoccur.

The paper, issued by the American Society of Clinical Oncologists (ASCO) and published July 12 in the Journal of Clinical Oncology essentially brings guidelines in alignment with today's practice.

"This is actually reinforcing clinical practice," said Dr. Crystal Denlinger, assistant professor of medical oncology at Fox Chase Cancer Center in Philadelphia. "In general, for postmenopausal women, we are offering them aromatase inhibitors based on the single studies that have been referenced [in these guidelines] and what has already been reported in national meetings."

Those studies and presentations, added Denlinger, "have uniformly demonstrated the superiority of aromatase inhibitors over tamoxifen or a switching strategy or an extended strategy."

The new guidelines replace previous guidelines issued in 2002, and subsequent updates in 2003 and 2004.

Tamoxifen has been a mainst
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Experts Believe Many Birth Defects Are Preventable
2. Experts Optimistic About Solving Puzzle of Alzheimers
3. Announcing: Intrinsic Imaging : Radiology Experts Launch Novel Medical Imaging CRO for Clinical Trials
4. Experts analyze benefits, opportunities and challenges of Medicare Part D
5. International child-health experts to converge on London for Excellence in Pediatrics
6. Experts explore emerging evidence linking diabetes and cancer
7. John Theurer Cancer Center experts present new cancer research at ASCO Annual Meeting
8. University Hospitals Case Medical Center experts present at ASCO Annual Meeting
9. Experts Advise At-Risk Diabetics to Begin Daily Aspirin Later
10. As Autism Web Sites Boom, Experts Urge Caution
11. Swimming Lessons OK for Toddlers, Experts Say
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Experts Issue New Guidelines on Breast Cancer Drugs
(Date:4/22/2014)... person we all seem to know who we say is ... she isn,t unable to act but simply doesn,t want to., ... A study of nearly 4,000 college students in 19 countries ... making decisions and moving forward with life. Turns out that ... they just don,t like it as much as non-neurotics. Therefore ...
(Date:4/22/2014)... is available in German . ... of the University of Vienna and the Medical University of ... shown how double stranded RNA, such as viral genetic information, ... the immune response against viral infection, the protein ADAR1 moves ... modifies viral RNA to inhibit reproduction of the virus. But ...
(Date:4/22/2014)... their total brain size suggests they have more ... according to a new study of 36 species ... zebra finches. , Scientists at Duke University, UC ... research institutions collaborated on this first large-scale investigation ... study as the ability to inhibit powerful but ...
(Date:4/22/2014)... familiar trope in science fiction: In enemy territory, activate ... to make themselves invisible to the immune system. Now ... have mimicked these viral tactics to build the first ... , The results pave the way for smart DNA ... and more accurately than doctors can today; target drugs ...
(Date:4/22/2014)... researchers have found that the anxiety experienced with ... negatively impact a woman,s overall well-being. Their findings ... which was published online in the April 21, ... from 40 to 60 percent of women who ... will experience a false-positive mammogram. Such mammograms require ...
Breaking Medicine News(10 mins):Health News:Neurotics don't just avoid action: They dislike it 2Health News:How the body fights against viruses 2Health News:How the body fights against viruses 3Health News:Brain size matters when it comes to animal self-control 2Health News:Brain size matters when it comes to animal self-control 3Health News:Cloaked DNA nanodevices survive pilot mission 2Health News:Cloaked DNA nanodevices survive pilot mission 3Health News:False-positive mammogram anxiety has limited impact on women's well-being 2
... Nutrition Inc. Chooses ,it, Girl PR to help promote their ... ... "it" Girl Public relations, one of,the leading Public Relations ... of Optimal Nutrition Inc. (O.N.I.).,O.N.I. bestows a customized door-to-door organic ...
... Group, a life sciences,focused, corporate, investor and public ... as agency of record by Agile Therapeutics, of,Princeton, ... Donna LaVoie, President and CEO, commented, "LaVoie ... tactical execution to these,exciting companies as they accelerate ...
... Expand Agency ... Representation in Massachusetts -, WORCESTER, Mass., Nov. 19 ... writer of auto, home and,business insurance in Massachusetts, announced today ... enhanced auto product that will,deliver highly- competitive prices and innovative ...
... Wealth Measures: Three-Quarters Say Governments, Should Look Beyond ... BRUSSELS, Belgium, Nov. 19 Three-quarters of,people in ... and include health, social and environmental statistics in,measuring ... growth,alone is the most important measure. Around ...
... CorVel Corporation,(Nasdaq: CRVL ) today announced ... stock under the stock repurchase program previously approved,by ... the Board had approved a,1,500,000 share expansion to ... has repurchased 862,323 shares, with a remaining 637,677,shares ...
... ThalesNano Inc.,and the Christian Doppler Laboratory ... Graz today announced a scientific,collaboration on flow/microwave ... application of flow reactors for organic synthesis ... background in,continuous processing. ThalesNano and the Christian ...
Cached Medicine News:Health News:'it' Girl Public Relations Adds 'O.N.I.' New Organic Food Delivery Service to Its Lifestyle Division 2Health News:LaVoie Group Adds Two New Companies to Its Life Science Client Roster 2Health News:The Hanover Seeks to Cut Auto Rates by Up to 30 Percent or More; Shave Three Years Off State's Existing Six-Year Surcharge Period 2Health News:The Hanover Seeks to Cut Auto Rates by Up to 30 Percent or More; Shave Three Years Off State's Existing Six-Year Surcharge Period 3Health News:The Hanover Seeks to Cut Auto Rates by Up to 30 Percent or More; Shave Three Years Off State's Existing Six-Year Surcharge Period 4Health News:GLOBESCAN Survey for the BEYOND GDP Conference, European Parliament, Nov. 19th and 20th 2Health News:GLOBESCAN Survey for the BEYOND GDP Conference, European Parliament, Nov. 19th and 20th 3Health News:CorVel Corporation Announces Resumption of Stock Repurchases 2Health News:CorVel Corporation Announces Resumption of Stock Repurchases 3Health News:ThalesNano Inc. and the Christian Doppler Laboratory for Microwave Chemistry in Graz, Austria Collaborate on Flow Chemistry Technologies 2Health News:ThalesNano Inc. and the Christian Doppler Laboratory for Microwave Chemistry in Graz, Austria Collaborate on Flow Chemistry Technologies 3
(Date:1/15/2014)... LAWRENCEVILLE, N.J. , Jan. 15, 2014  Celsion Corporation (the ... it has received commitments from institutional investors to purchase ... common stock in an at-the-market registered direct offering, led ... Company entered into definitive purchase agreements with these investors ...
(Date:1/15/2014)... 2014 Shire plc (LSE: SHP, NASDAQ: ... Trading (OFT) approval condition to the announced tender offer for all ... As a result of the waiver, the transaction is no ... tender offer on January 24, 2014 following the currently scheduled expiration ...
(Date:1/15/2014)... , January 15, 2014 BreedIT ... the exclusive worldwide distributor of highly sophisticated agro-breeding solutions ... January 7, 2014, the Company,s board of directors appointed ... as its new member of the board. ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3
... SILVER SPRING, Md., June 14, 2011 The U.S. ... test that will help health care professionals determine if ... for Herceptin (trastuzumab), a commonly used breast cancer treatment. ... The test, called Inform Dual ISH, allows for measurement ...
... June 14, 2011 Viral Genetics, Inc. (Pinksheets: ... clinical-stage company. The Company,s two lead pharmaceutical programs ... (MDT) compounds for drug-resistant cancers -- are being ... Investigational New Drug (IND) pathways. An IND application ...
Cached Medicine Technology:FDA Approves New Test To Help Determine if Breast Cancer Patients Are Candidates for Herceptin Treatment 2FDA Approves New Test To Help Determine if Breast Cancer Patients Are Candidates for Herceptin Treatment 3Viral Genetics Updates HIV/AIDS and Drug Resistant Cancer Research Programs 2Viral Genetics Updates HIV/AIDS and Drug Resistant Cancer Research Programs 3Viral Genetics Updates HIV/AIDS and Drug Resistant Cancer Research Programs 4
... Single Use Loading Units With ... ILA™ 75 (Single Use Reloadable ... ,INDICATIONS The ILA™ 75 single-use ... for use in the resection, ...
... The Auto Suture™ GIA™ Reloadable Staplers ... application in abdominal, gynecological, pediatric and ... and creation of anastomosis. , ... and the SGIA™ Knifeless Stapler have ...
... Staplers are anastomotic staplers available in four ... to lumen diameter. The staplers permit tissue ... improve access and ease of use. The ... compression by adjusting the height of the ...
... ENDOPATH STEALTH Intraluminal Staplers are anastomotic ... proper matching of instrument to lumen diameter. ... detachable anvil head to improve access and ... surgeon to control tissue compression by adjusting ...
Medicine Products: